Finance entity

Oncobiologics, Inc.

Company OTLK

All 1 tracked stories fall under one category: earnings. Of the tracked stories, 1 of 1 also mention Faisal Ghiath Sukhtian, the most common co-covered peer. Source depth averages 2 original sources per story, versus 2.1 across the same-window beat baseline.

Last mentioned: 2h ago

RSS updates
Share

Entity pulse

Recent coverage · Oncobiologics, Inc.

1 story
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Oncobiologics, Inc.

All 1 tracked stories fall under one category: earnings. Of the tracked stories, 1 of 1 also mention Faisal Ghiath Sukhtian, the most common co-covered peer. Source depth averages 2 original sources per story, versus 2.1 across the same-window beat baseline. At 5, the average consequence score sits below the same-window beat average of 5.5. We currently track 1 Finance story that mention Oncobiologics, Inc., all published on August 16, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 32 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Oncobiologics, Inc.. Shared-story counts are live from our verified record — not editorial picks.

Key Data

ticker
OTLK
name
Oncobiologics, Inc.
price
0.76
change
-0.13
changePct
-14.61

Stories mentioning Oncobiologics, Inc. 1

Oncobiologics, Inc. is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.